PRRT2 and cancer: Given that high PKC-θ expression has been shown to enhance the proliferation and migration of cancer cells [53,54], we next investigated the effect of nPKC-θi2 inhibition on breast cancer, melanoma, and immunotherapy-resistant cancer cell lines.